Novo Nordisk

News

Novo Nordisk buys another obesity biotech

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 milli

News

Semaglutide scores again, this time in heart failure

The list of benefits for Novo Nordisk's semaglutide keeps getting longer.

News

Amazon Pharmacy rolls out insulin discount coupons

Amazon Pharmacy has said that it will automatically apply manufacturer coupons on over 15 insulin and diabetes care products from manufacturers like Novo Nordisk, Eli Lill

News

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Sales of its obesity therapies may be accelerating, but Novo Nordisk is showing no signs of pushing the brake pedal on investments in the category.

News

Advantage Novo Nordisk in battle of weight-loss drugs

Novo Nordisk has claimed an edge in the increasingly competitive obesity therapy category after reporting that its Wegovy therapy reduced cardiovascular outcomes by 20% in

News

Lilly, Novo Nordisk sued over GLP-1 drug safety

A lawsuit has been filed in the US claiming that Novo Nordisk and Eli Lilly failed to warn of severe gastrointestinal side effects that can be caused by their incretin mim

Novo Nordisk buys another obesity biotech

Semaglutide scores again, this time in heart failure

Amazon Pharmacy rolls out insulin discount coupons

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Advantage Novo Nordisk in battle of weight-loss drugs

Lilly, Novo Nordisk sued over GLP-1 drug safety

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Novo Nordisk

Editor's Picks